Skip to main content
. 2022 Jun 21;2022(6):CD006404. doi: 10.1002/14651858.CD006404.pub4

1.19. Analysis.

1.19

Comparison 1: Pyronaridine‐artesunate versus artemether‐lumefantrine, Outcome 19: Paediatric trials ‐ first treatment, AST increase > 5 × ULN